SCHEMBL5383454

SCHEMBL5383454

Oc1nc2ccccc2nc1C1CCNCC1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SLC18A3 Q16572 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
GABRA1 P14867 4/20 0.40
GABRB2 P47870 4/20 0.40
HTR2C P28335 7/20 0.40
QDPR P09417 1/20 0.39
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
MAOB P27338 1/20 0.38
HTR6 P50406 1/20 0.38
USP7 Q93009 2/20 0.37
ILK Q13418 1/20 0.36
ADRB2 P07550 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28834199 0.71 KMT2A (0.43) MEN1KMT2ASLC18A3SIGMAR1GABRA1
Hydrochloric Acid SCHEMBL3889358 0.70 PLAUR (0.47) MEN1KMT2A
SCHEMBL7700269 0.70 PDE10A (0.50) MEN1KMT2ASLC18A3SIGMAR1GABRA1
SCHEMBL6222895 0.69 MEN1 (0.41) MEN1KMT2ASLC18A3SIGMAR1GABRA1
SCHEMBL29590357 0.69 MEN1 (0.55) MEN1KMT2ASLC18A3SIGMAR1GABRA1
SCHEMBL3703819 0.69 MEN1 (0.55) MEN1KMT2ASLC18A3SIGMAR1GABRA1
SCHEMBL6975725 0.69 NUDT1 (0.53) MEN1KMT2ASLC18A3SIGMAR1HTR2C
SCHEMBL23877258 0.68 MAPT (0.56) MEN1KMT2ABCHEACHEILK
Hydrochloric Acid SCHEMBL3709193 0.68 MEN1 (0.54) MEN1KMT2ASLC18A3SIGMAR1GABRA1
SCHEMBL30735510 0.68 MEN1 (0.43) MEN1KMT2ASLC18A3SIGMAR1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809633-A1 CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS Brystol-Myers Squibb Company (US) 2007-07-25 EP disclosed
WO-2006052378-A1 CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2006-05-18 WO disclosed